NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

醫療用高性能塑膠的全球市場 (∼2026年):各類型 (FP、HPPA、PAEK、PPS、PEI)、用途 (醫療用品、醫療設備&工具、藥物輸送、人工替代物&植入、治療系統)、地區

High Performance Medical Plastics Market by Type (FP, HPPA, PAEK, PPS, PEI), Application (Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System), Region - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1006618
出版日期 內容資訊 英文 206 Pages
訂單完成後即時交付
價格
醫療用高性能塑膠的全球市場 (∼2026年):各類型 (FP、HPPA、PAEK、PPS、PEI)、用途 (醫療用品、醫療設備&工具、藥物輸送、人工替代物&植入、治療系統)、地區 High Performance Medical Plastics Market by Type (FP, HPPA, PAEK, PPS, PEI), Application (Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System), Region - Global Forecast to 2026
出版日期: 2021年05月17日內容資訊: 英文 206 Pages
簡介

全球醫療用高性能塑膠的市場規模在預測期間內預計以7.8%的年複合成長率發展,從2021年的8億5100萬美元,成長到2026年12億4200萬美元的規模。

可支配所得增加,生活方式的變化,新興國家的人口增加等為背景,醫療保健解決方案的需求高漲,成為該市場成長的原動力。

各用途中,人工替代物及植入物的部門在預測期間內預計以最大的年複合成長率成長。還有各類型中,預計PAEK的部門預測期間內顯示最大的年複合成長率。

本報告提供全球醫療用高性能塑膠的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,技術、專利趨勢,案例研究,市場規模的變化、預測,類型、用途、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 產業趨勢

  • 關稅、規定
  • 宏觀經濟分析
  • 案例研究
  • 價格分析
  • 技術分析
  • 價值鏈分析
  • COVID-19的影響
  • 影響客戶事業的趨勢
  • 生態系統、市場地圖
  • 專利分析

第7章 市場分析、預測:各類型

  • FP
    • PTFE
    • FEP
    • PVDF
  • HPPA
    • PA 11
    • PA 12
    • PPA
  • PPS
    • PPSU
    • PES
    • PSU
  • PAEK
    • PEEK
    • PEKK
  • PEI
  • 其他

第8章 市場分析、預測:各用途

  • 醫療用品
  • 醫療設備、工具
    • 手術器具
    • 牙科用工具
    • 設備零組件
  • 人工替代物、植入
    • 義肢
    • 植入
  • 藥物輸送
  • 治療系統
  • 其他

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 亞太地區
  • 歐洲
  • 中東、非洲
  • 南美

第10章 競爭情形

  • 前五名公司的收益分析
  • 市場佔有率分析
  • 企業評估象限
  • Start-Ups/SME評估象限
  • 競爭模式

第11章 企業簡介

  • 主要企業
    • SOLVAY SA
    • SABIC
    • MITSUBISHI CHEMICAL HOLDINGS
    • EVONIK INDUSTRIES AG
    • ARKEMA SA
    • CELANESE CORPORATION
    • ENSINGER
    • VICTREX PLC
    • ROCHLING SE & CO. KG
    • RAUMEDIC AG
    • THE CHEMOURS COMPANY
    • DUPONT
    • SAINT-GOBAIN PERFORMANCE PLASTICS
    • TRELLEBORG
    • TEKNI-PLEX
  • 其他的主要企業
    • BIOMERICS
    • RTP COMPANY
    • GUJRAT FLUOROCHEMICALS LTD.
    • DRAKE MEDICAL PLASTICS
    • PERFORMANCE PLASTICS LTD
    • BOLLINGER GROUP
    • CHINA ARRAY PLASTICS
    • EXTRA PLASTIC CO. LTD.
    • SPECTRUM PLASTIC GROUP
    • STRATASYS

第12章 附錄

目錄
Product Code: CH 7900

The global high performance medical plastics market size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. The increasing demand for healthcare solutions owing to an increase in disposable income, changing lifestyles, and growing population in emerging economies are some of the drivers for the high performance medical plastics market to grow.

"The prosthesis & implants application segment is projected to grow at the highest CAGR during the forecast period."

Based on application, the prosthesis & implants segment is projected to grow at the highest CARG during the forecast period. Prosthesis & Implants are artificial devices, which are used to replace a missing body part that may be lost due to some diseases or accidents. Prosthetics are intended to restore the normal functioning of the body part. The rapid growth of this segment can be attributed to the increasing adoption of prosthesis and dental implants in emerging economies such as China, India, and other south Asian countries.

"The PAEK type segment is projected to grow at the highest CAGR during the forecast period."

Based on type, the PAEK segment is projected to grow at the highest CARG during the forecast period. PAEK polymers are categorized into three major types- Polyether Ether Ketone (PEEK), Polyether Ketone (PEK), and Polyetherketoneketone (PEKK). PAEK has the highest unit price in comparison to other HPPs due to its superior characteristics, including excellent high-temperature performance, inherent purity, excellent combustion resistance, good resistance to all organic chemicals, good electrical properties, and processability. The rapid growth of this segment can be attributed to the increasing demand for PEEK in prosthesis and dental implant applications.

"Asia Pacific is projected to grow the highest CAGR in the high performance medical plastics market during the forecast period."

Asia Pacific is projected to grow at the highest CAGR in the high performance medical plastics market from 2021 to 2026. The medical device manufacturing industry is expected to expand rapidly in the region in the next five years. As a result, the demand for high performance medical plastics is expected to grow in APAC. In addition, growth in the aging population and the advent of new technologies such as robotic assistance, use of big data, 3D printed customized prostheses, and others are also expected to drive the high performance medical plastics market in APAC during the forecast period.

Profile break-up of primary participants for the report:

  • By Company Type: Tier 1 - 25%, Tier 2 - 50%, and Tier 3 - 25%
  • By Designation: C-level Executives - 20%, Directors - 30%, and Others - 50%
  • By Region: Asia Pacific - 25%, Europe - 30%, North America - 20%, Middle East & Africa - 15%, and South America - 10%

Furthermore, as a part of the qualitative analysis of the high performance medical plastics market, the research provides a comprehensive review of drivers, restraints, opportunities, and challenges influencing the growth of the market across the globe. It also discusses competitive strategies adopted by the leading market players such as Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastic (France), Celanese Corporation (US), Trelleborg (Sweden), and Tekni-Plex (US), among others.

Research Coverage:

The report defines, segments, and projects the size of the high performance medical plastics market based on material, distribution channel, end use and region. It strategically profiles the key players and comprehensively analyzes their market share and core competencies. It also tracks and analyzes competitive developments such as mergers & acquisitions, investments, joint ventures, new product launches, and expansions undertaken by them in the market.

Key Benefits of Buying the Report:

The report is expected to help the market leaders/new entrants in the market by providing them the closest approximations of revenue numbers of the high performance medical plastics market and its segments. This report is also expected to help stakeholders obtain an improved understanding of the competitive landscape of the market, gain insights to improve the position of their businesses, and make suitable go-to-market strategies. It also enables stakeholders to understand the pulse of the market and provide them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 HIGH PERFORMANCE MEDICAL PLASTICS MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
  • 1.4 INCLUSIONS & EXCLUSIONS
    • TABLE 1 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE: INCLUSIONS & EXCLUSIONS
    • TABLE 2 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION: INCLUSIONS & EXCLUSIONS
    • 1.4.1 YEARS CONSIDERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 UNIT CONSIDERED
  • 1.7 STAKEHOLDERS
  • 1.8 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
  • 2.2 BASE NUMBER CALCULATION
    • 2.2.1 SUPPLY-SIDE APPROACH (VOLUME)
    • 2.2.2 SUPPLY-SIDE APPROACH (VALUE)
    • 2.2.3 DEMAND-SIDE APPROACH
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 2 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 3 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: TOP-DOWN APPROACH
  • 2.4 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • 2.4.1 SUPPLY SIDE
    • FIGURE 4 HISTORICAL GROWTH RATES OF COMPANIES IN THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET
  • 2.5 DATA TRIANGULATION
    • FIGURE 5 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: DATA TRIANGULATION
    • 2.5.1 HIGH PERFORMANCE MEDICAL PLASTICS MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
  • 2.6 LIMITATIONS
  • 2.7 ASSUMPTIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

    • FIGURE 6 MEDICAL EQUIPMENT& TOOLS SEGMENT IS THE LARGEST APPLICATION OF HIGH PERFORMANCE MEDICAL PLASTICS
    • FIGURE 7 FP SEGMENT IS THE LARGEST TYPE OF HIGH PERFORMANCE MEDICAL PLASTICS
    • FIGURE 8 APAC TO BE THE FASTEST-GROWING HIGH PERFORMANCE MEDICAL PLASTICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET
    • FIGURE 9 GROWING DEMAND IN EMERGING ECONOMIES TO DRIVE THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET
  • 4.2 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE
    • FIGURE 10 PAEK TO BE THE LARGEST TYPE OF HIGH PERFORMANCE MEDICAL PLASTIC
  • 4.3 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY REGION
    • FIGURE 11 APAC TO BE FASTEST-GROWING MARKET BETWEEN 2021 AND 2026
  • 4.4 HIGH PERFORMANCE MEDICAL PLASTICS MARKET IN NORTH AMERICA, BY COUNTRY AND TYPE
    • FIGURE 12 THE US ACCOUNTED FOR THE LARGEST SHARE IN NORTH AMERICA
  • 4.5 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY MAJOR COUNTRIES
    • FIGURE 13 INDIA TO REGISTER THE HIGHEST CAGR

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population demands advanced medical technologies and devices
    • TABLE 3 REGION-WISE TRENDS FOR GERIATRIC POPULATION
      • 5.2.1.2 Growing healthcare investments in emerging economies
    • TABLE 4 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP
      • 5.2.1.3 Shift toward minimally invasive medical procedures
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Time-consuming regulatory approval process
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 R&D to develop advanced plastics
      • 5.2.3.2 Development of patient-specific implants and 3D printed devices
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Waste management concerns
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 15 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY

6 INDUSTRY TRENDS

  • 6.1 TARIFFS & REGULATIONS
    • 6.1.1 TARIFFS
    • TABLE 6 NUMBER OF WTO MEMBERS PER AVERAGE MFN APPLIED TARIFF BAND AND AVERAGE MFN TARIFF
    • 6.1.2 REGULATIONS
      • 6.1.2.1 US
      • 6.1.2.2 Europe
      • 6.1.2.3 Country-wise regulations
    • TABLE 7 LEGAL FRAMEWORK AND REGULATORY AUTHORITIES FOR MEDICAL DEVICES IN MAJOR COUNTRIES
  • 6.2 MACROECONOMIC ANALYSIS
    • TABLE 8 MACROECONOMIC ANALYSIS OF MAJOR COUNTRIES
  • 6.3 CASE STUDY ANALYSIS
  • 6.4 PRICING ANALYSIS
    • FIGURE 16 HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY REGION
    • TABLE 9 HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY REGION, 2019-2026 (USD/KG)
    • TABLE 10 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY TYPE, 2019-2026 (USD/KG)
    • TABLE 11 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY TYPE, 2019-2026 (USD/KG)
    • TABLE 12 APAC: HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY TYPE, 2019-2026 (USD/KG)
    • TABLE 13 MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY TYPE, 2019-2026 (USD/KG)
    • TABLE 14 SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS AVERAGE SELLING PRICE, BY TYPE, 2019-2026 (USD/KG)
  • 6.5 TECHNOLOGY ANALYSIS
  • 6.6 VALUE CHAIN ANALYSIS
    • FIGURE 17 VALUE CHAIN ANALYSIS FOR HIGH PERFORMANCE MEDICAL PLASTICS
    • 6.6.1 RAW MATERIAL SUPPLIERS
    • 6.6.2 RESIN MANUFACTURERS
    • 6.6.3 DISTRIBUTORS/CONVERTORS
    • 6.6.4 OEM/MEDICAL DEVICE MANUFACTURERS
  • 6.7 IMPACT OF COVID-19 ON HIGH PERFORMANCE MEDICAL PLASTICS MARKET
    • 6.7.1 COVID-19
    • 6.7.2 COVID-19 HEALTH ASSESSMENT
    • FIGURE 18 COUNTRY-WISE SPREAD OF COVID-19
    • FIGURE 19 IMPACT OF COVID-19 ON DIFFERENT COUNTRIES IN 2020 (Q4)
    • FIGURE 20 THREE SCENARIO-BASED ANALYSES OF COVID-19 IMPACT ON THE GLOBAL ECONOMY
    • 6.7.3 IMPACT ON HIGH PERFORMANCE MEDICAL PLASTICS MARKET
  • 6.8 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 21 YC-YCC SHIFT FOR HIGH PERFORMANCE MEDICAL PLASTICS MARKET
  • 6.9 ECOSYSTEM/MARKET MAP OF HIGH PERFORMANCE MEDICAL PLASTICS
    • FIGURE 22 ECOSYSTEM/MARKET MAP OF HIGH PERFORMANCE MEDICAL PLASTICS
    • TABLE 15 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: ECOSYSTEM
  • 6.10 PATENT ANALYSIS
    • 6.10.1 INTRODUCTION
    • FIGURE 23 PUBLICATION TRENDS (2012-2020)
    • 6.10.2 INSIGHTS
    • FIGURE 24 TREND ANALYSIS AND GRAPHICAL REPRESENTATION
    • 6.10.3 TOP ASSIGNEES

7 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • FIGURE 25 PAEK TO DOMINATE THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET IN TERMS OF VALUE
    • TABLE 16 HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2019-2026 (TON)
    • TABLE 17 HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
  • 7.2 FP
    • 7.2.1 PTFE IS THE MOST WIDELY USED FLUOROPOLYMER
    • 7.2.2 PTFE
    • 7.2.3 FEP
    • 7.2.4 PVDF
    • TABLE 18 FP: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 19 FP: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 HPPA
    • 7.3.1 HPPA ACCOUNTS FOR THE SECOND-LARGEST MARKET SHARE
    • 7.3.2 PA 11
    • 7.3.3 PA 12
    • 7.3.4 PPA
    • TABLE 20 HPPA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 21 HPPA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 PPS
    • 7.4.1 MAINLY USED IN STERILIZATION APPLICATIONS
    • 7.4.2 PPSU
    • 7.4.3 PES
    • 7.4.4 PSU
    • TABLE 22 PPS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 23 PPS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 PAEK
    • 7.5.1 HIGHEST UNIT PRICE COMPARED TO OTHER HIGH PERFORMANCE MEDICAL PLASTICS
    • 7.5.2 PEEK
    • 7.5.3 PEKK
    • TABLE 24 PAEK: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 25 PAEK: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 PEI
    • 7.6.1 SECOND-FASTEST-GROWING HIGH PERFORMANCE MEDICAL PLASTIC
    • TABLE 26 PEI: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 27 PEI: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.7 OTHERS
    • TABLE 28 OTHERS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 29 OTHERS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)

8 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • FIGURE 26 MEDICAL EQUIPMENT & TOOLS TO DOMINATE THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET
    • TABLE 30 HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2019-2026 (TON)
  • 8.2 MEDICAL SUPPLIES
    • 8.2.1 EXTENSIVE USE OF HIGH PERFORMANCE MEDICAL PLASTICS IN CATHETERS
    • TABLE 31 MEDICAL SUPPLIES: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
  • 8.3 MEDICAL EQUIPMENT & TOOLS
    • 8.3.1 3D PRINTING TO DRIVE THE MARKET GROWTH
    • 8.3.2 SURGICAL INSTRUMENTS
    • 8.3.3 DENTAL TOOLS
    • 8.3.4 DEVICE COMPONENTS
    • TABLE 32 MEDICAL EQUIPMENT & TOOLS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
  • 8.4 PROSTHESIS & IMPLANTS
    • 8.4.1 FASTEST-GROWING APPLICATION SEGMENT
    • 8.4.2 LIMB PROSTHETICS
    • 8.4.3 IMPLANTS
    • TABLE 33 PROSTHESIS & IMPLANTS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
  • 8.5 DRUG DELIVERY
    • 8.5.1 RISING DEMAND FOR INNOVATIVE DRUGS TO DRIVE THE GROWTH OF THE SEGMENT
    • TABLE 34 DRUG DELIVERY: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
  • 8.6 THERAPEUTIC SYSTEM
    • 8.6.1 SECOND-FASTEST-GROWING APPLICATION SEGMENT
    • TABLE 35 THERAPEUTIC SYSTEM: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • 8.6.2 OTHERS
    • TABLE 36 OTHERS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)

9 HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 27 HIGH PERFORMANCE MEDICAL PLASTICS MARKET IN INDIA TO REGISTER THE HIGHEST CAGR
    • TABLE 37 HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (TON)
    • TABLE 38 HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SNAPSHOT
    • TABLE 39 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (TON)
    • TABLE 40 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 41 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2021-2026 (TON)
    • TABLE 42 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 43 NORTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The country's advanced medical technology industry is the major driver for the market
    • TABLE 44 US: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 45 US: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 The high performance medical plastics market in the country is highly regulated
    • TABLE 46 CANADA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 47 CANADA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.2.3 MEXICO
      • 9.2.3.1 The country is one of the most prominent medical device markets in the region
    • TABLE 48 MEXICO: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 49 MEXICO: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
  • 9.3 APAC
    • FIGURE 29 APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SNAPSHOT
    • TABLE 50 APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (TON)
    • TABLE 51 APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 52 APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2021-2026 (TON)
    • TABLE 53 APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 54 APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.3.1 CHINA
      • 9.3.1.1 The country attracts international investments in medical device manufacturing units
    • TABLE 55 CHINA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 56 CHINA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.3.2 JAPAN
      • 9.3.2.1 The implementation of AI and big data technologies in the healthcare industry is favorable for the market
    • TABLE 57 JAPAN: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 58 JAPAN: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.3.3 SOUTH KOREA
      • 9.3.3.1 There has been increased domestic manufacturing of smart medical devices in the country
    • TABLE 59 SOUTH KOREA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 60 SOUTH KOREA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.3.4 INDIA
      • 9.3.4.1 Government initiatives for the healthcare sector to boost the demand
    • TABLE 61 INDIA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 62 INDIA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.3.5 REST OF APAC
    • TABLE 63 REST OF APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 64 REST OF APAC: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
  • 9.4 EUROPE
    • FIGURE 30 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SNAPSHOT
    • TABLE 65 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (TON)
    • TABLE 66 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 67 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2019-2026 (TON)
    • TABLE 68 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 69 EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.1 GERMANY
      • 9.4.1.1 The country is the largest market for dental equipment in Europe
    • TABLE 70 GERMANY: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 71 GERMANY: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.2 FRANCE
      • 9.4.2.1 Non-invasive surgery and orthopedics segments offer opportunities for medical device manufacturers
    • TABLE 72 FRANCE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 73 FRANCE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.3 UK
      • 9.4.3.1 The highly-regulated healthcare industry and strong medical devices market are the driving factors for the market
    • TABLE 74 UK: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 75 UK: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.4 ITALY
      • 9.4.4.1 Italy has an established healthcare industry
    • TABLE 76 ITALY: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 77 ITALY: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.5 SPAIN
      • 9.4.5.1 Public hospitals, health centers, and research institutions are the major consumers of medical devices in the country
    • TABLE 78 SPAIN: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 79 SPAIN: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.6 NETHERLANDS
      • 9.4.6.1 The country is witnessing extensive R&D on medical instrumentation
    • TABLE 80 NETHERLANDS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 81 NETHERLANDS: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.4.7 REST OF EUROPE
    • TABLE 82 REST OF EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 83 REST OF EUROPE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
  • 9.5 MIDDLE EAST & AFRICA
    • TABLE 84 MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (TON)
    • TABLE 85 MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 86 MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2021-2026 (TON)
    • TABLE 87 MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 88 MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.5.1 SAUDI ARABIA
      • 9.5.1.1 Initiatives, such as NTP and Vision 2030, are expected to drive the market in Saudi Arabia
    • TABLE 89 SAUDI ARABIA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 90 SAUDI ARABIA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.5.2 UAE
      • 9.5.2.1 The Dubai Industrial Strategy (DIS) 2030 is expected to create opportunities for the market
    • TABLE 91 UAE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 92 UAE: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.5.3 SOUTH AFRICA
      • 9.5.3.1 The high performance medical plastics market to grow due to the launch of government schemes
    • TABLE 93 SOUTH AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 94 SOUTH AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.5.4 REST OF MIDDLE EAST & AFRICA
    • TABLE 95 REST OF MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 96 REST OF MIDDLE EAST & AFRICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
  • 9.6 SOUTH AMERICA
    • TABLE 97 SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (TON)
    • TABLE 98 SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 99 SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2021-2026 (TON)
    • TABLE 100 SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 101 SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.6.1 BRAZIL
      • 9.6.1.1 Brazil has a strong healthcare demographic growth
    • TABLE 102 BRAZIL: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 103 BRAZIL: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.6.2 ARGENTINA
      • 9.6.2.1 The country is an important location for medical tourism
    • TABLE 104 ARGENTINA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 105 ARGENTINA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)
    • 9.6.3 REST OF SOUTH AMERICA
    • TABLE 106 REST OF SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (TON)
    • TABLE 107 REST OF SOUTH AMERICA: HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2021-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
    • FIGURE 31 COMPANIES ADOPTED PRODUCT LAUNCH AS THE KEY GROWTH STRATEGY BETWEEN 2019 AND 2021
  • 10.2 REVENUE ANALYSIS FOR TOP FIVE COMPANIES
    • FIGURE 32 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET FROM 2016 TO 2020
  • 10.3 MARKET SHARE ANALYSIS, 2020
    • FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN THE HIGH PERFORMANCE MEDICAL PLASTICS MARKET, 2020
    • TABLE 108 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: DEGREE OF COMPETITION
  • 10.4 COMPANY EVALUATION QUADRANT
    • 10.4.1 STAR
    • 10.4.2 PERVASIVE
    • 10.4.3 EMERGING LEADER
    • 10.4.4 PARTICIPANT
    • FIGURE 34 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: COMPANY EVALUATION MATRIX 2020
    • 10.4.5 HIGH PERFORMANCE MEDICAL PLASTICS MARKET
    • TABLE 109 COMPANY PRODUCT FOOTPRINT
    • TABLE 110 PRODUCT TYPE FOOTPRINT OF COMPANIES
    • TABLE 111 APPLICATION FOOTPRINT OF COMPANIES
    • TABLE 112 REGIONAL FOOTPRINT OF COMPANIES
  • 10.5 STARTUP/SME EVALUATION QUADRANT, 2020
    • 10.5.1 PROGRESSIVE COMPANY
    • 10.5.2 RESPONSIVE COMPANY
    • 10.5.3 DYNAMIC COMPANY
    • 10.5.4 STARTING BLOCK
    • FIGURE 35 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: STARTUP/SME EVALUATION QUADRANT, 2020
  • 10.6 COMPETITIVE SCENARIO
    • FIGURE 36 HIGH PERFORMANCE MEDICAL PLASTICS MARKET EVALUATION FRAMEWORK OF KEY COMPANIES
    • 10.6.1 DEALS
    • TABLE 113 HIGH PERFORMANCE MEDICAL PLASTICS MARKET: DEALS, JANUARY 2018-MARCH 2021
    • 10.6.2 PRODUCT LAUNCHES
    • TABLE 114 PRODUCT LAUNCH, 2019-2021
    • 10.6.3 OTHER DEVELOPMENTS
    • TABLE 115 OTHER DEVELOPMENTS, 2019-2021

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)**
  • 11.1 KEY PLAYERS
    • 11.1.1 SOLVAY SA
    • TABLE 116 SOLVAY SA: COMPANY OVERVIEW
    • FIGURE 37 SOLVAY SA: COMPANY SNAPSHOT
    • 11.1.2 SABIC
    • TABLE 117 SABIC: COMPANY OVERVIEW
    • FIGURE 38 SABIC: COMPANY SNAPSHOT
    • 11.1.3 MITSUBISHI CHEMICAL HOLDINGS
    • TABLE 118 MITSUBISHI CHEMICAL HOLDINGS: COMPANY OVERVIEW
    • FIGURE 39 MITSUBISHI CHEMICAL HOLDINGS: COMPANY SNAPSHOT
    • 11.1.4 EVONIK INDUSTRIES AG
    • TABLE 119 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
    • FIGURE 40 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
    • 11.1.5 ARKEMA SA
    • TABLE 120 ARKEMA: COMPANY OVERVIEW
    • FIGURE 41 ARKEMA SA: COMPANY SNAPSHOT
    • 11.1.6 CELANESE CORPORATION
    • TABLE 121 CELANESE CORPORATION: COMPANY OVERVIEW
    • FIGURE 42 CELANESE CORPORATION: COMPANY SNAPSHOT
    • 11.1.7 ENSINGER
    • 11.1.8 VICTREX PLC
    • TABLE 122 VICTREX PLC: COMPANY OVERVIEW
    • FIGURE 43 VICTREX PLC: COMPANY SNAPSHOT
    • 11.1.9 ROCHLING SE & CO. KG
    • 11.1.10 RAUMEDIC AG
    • 11.1.11 THE CHEMOURS COMPANY
    • TABLE 123 THE CHEMOURS COMPANY: COMPANY OVERVIEW
    • FIGURE 44 THE CHEMOURS COMPANY: COMPANY SNAPSHOT
    • 11.1.12 DUPONT
    • TABLE 124 DUPONT: COMPANY OVERVIEW
    • FIGURE 45 DUPONT: COMPANY SNAPSHOT
    • 11.1.13 SAINT-GOBAIN PERFORMANCE PLASTICS
    • 11.1.14 TRELLEBORG
    • FIGURE 46 TRELLEBORG: COMPANY SNAPSHOT
    • 11.1.15 TEKNI-PLEX
  • 11.2 OTHER COMPANIES
    • 11.2.1 BIOMERICS
    • 11.2.2 RTP COMPANY
    • 11.2.3 GUJRAT FLUOROCHEMICALS LTD.
    • 11.2.4 DRAKE MEDICAL PLASTICS
    • 11.2.5 PERFORMANCE PLASTICS LTD
    • 11.2.6 BOLLINGER GROUP
    • 11.2.7 CHINA ARRAY PLASTICS
    • 11.2.8 EXTRA PLASTIC CO. LTD.
    • 11.2.9 SPECTRUM PLASTIC GROUP
    • 11.2.10 STRATASYS
  • *Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS